{"uid":"cap_mpkBezafopYAEE_ETz3Xx","slug":"pharmacatalyst-2e2ea36c","name":"PharmaCatalyst","description":"Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=)","url":"https://pharma.lonestaroracle.xyz/catalysts","method":"GET","headers":{},"bodySchema":{"name":"PharmaCatalyst","tags":["biotech","pharma","catalyst","clinical-trials","healthcare"],"type":"object","version":"1.0.0","category":"markets","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"days":{"type":"integer","default":365,"description":"Look-ahead horizon in days (default 365, max 1095). Alias: horizon."},"ticker":{"type":"string","example":"SRPT","description":"Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol."},"company":{"type":"string","description":"Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name."}}}}},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}}},"description":"Biotech catalyst tracking made agent-callable. One x402 call takes a stock ticker (or company name) and returns a catalyst signal (HIGH / MODERATE / LOW / NONE) plus the company's upcoming late-stage clinical-trial readouts — the binary events that move biotech stocks 50-90% in a day. Each catalyst names the phase (2 or 3), the indication, the expected primary-completion date (the data-release proxy), how many days out it is, the trial status and the ClinicalTrials.gov NCT id. The biotech analog of an earnings calendar, served pay-per-call: a trading, research or risk agent asks 'what's coming for $SRPT' and gets the readout schedule. $0.05 in USDC on Base via x402. Sources: ClinicalTrials.gov API v2 (official) + yfinance for ticker resolution (all free/public). NOTE: this is the trial-readout leg — it does NOT include curated FDA PDUFA decision dates (no free feed exists for those). Companion to EquityScope, OptionsFlow, AnalystEdge and EarningsCalendar."},"responseSchema":null,"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.05","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.05/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.05","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.05","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_U5wHtgrmeZIv_JEgd2Tei","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.05","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns upcoming biotech clinical-trial catalyst signals (HIGH/MODERATE/LOW/NONE) and late-stage readout schedules for a given stock ticker or company name","exampleAgentPrompt":"What's the catalyst signal for Sarepta Therapeutics — do they have any Phase 2 or Phase 3 trial readouts coming up in the next 365 days, and how binary is the near-term risk?","exampleUseCases":[{"title":"Pre-earnings biotech position check","prompt":"I'm looking at taking a position in SRPT before their next earnings — can you pull their upcoming clinical trial readouts and tell me if there's a HIGH catalyst risk from any Phase 3 binary events in the next 90 days?"},{"title":"Biotech watchlist catalyst sweep","prompt":"I've got VRTX, MRNA, and REGN on my watchlist — for each one, can you check if there are any upcoming Phase 3 trial readouts in the next year and flag which ones have a HIGH or MODERATE catalyst signal?"},{"title":"Company-name clinical pipeline lookup","prompt":"Can you look up Vertex Pharmaceuticals by name and show me all their upcoming late-stage clinical trial catalysts over the next two years, including what indication each trial covers and when the data readout is expected?"}],"resultDescription":"Returns a catalyst signal level (HIGH, MODERATE, LOW, or NONE), a count of upcoming Phase 2 and Phase 3 trials, how many are due within 90 days, and a list of individual upcoming catalyst events each containing the trial phase, indication, NCT ID, expected readout date, days until readout, trial status, and lead sponsor — sourced from ClinicalTrials.gov API v2.","failureModes":["Unknown ticker: yfinance cannot resolve the ticker to a company, returns no match","Unknown company: company name string matches no sponsor in ClinicalTrials.gov, returns empty catalysts","No upcoming trials: company exists but has no late-stage trials in the horizon window, catalyst_signal returns NONE","Ambiguous company name: partial name matches multiple sponsors, results may be incomplete","Horizon out of range: days parameter exceeds 1095, likely returns a validation error","Rate limiting or network error from upstream ClinicalTrials.gov API causing delayed or failed response","Micropayment failure: x402 payment of $0.05 USDC not completed, request rejected"],"whenToPreferThis":"Choose this endpoint when you need structured, machine-readable biotech catalyst data tied to a specific stock ticker or company, particularly for pre-trade research, risk assessment of binary clinical events, or monitoring upcoming Phase 2/3 readouts that could move a stock 50-90%. Prefer this over generic financial data APIs when the specific question is about clinical trial timelines and catalyst risk classification rather than price, volume, or earnings data.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-14T18:39:16.588Z","isFirstParty":false}